Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo

by Rahul Shukla, Ravi K. Rajpoot, Upasana Arora, Ankur Poddar, Sathyamangalam Swaminathan, Navin Khanna, Navin Khanna, Navin Khanna
Published 2018-01-01

Dengue vaccine development: Global and Indian scenarios

by Sathyamangalam Swaminathan, Navin Khanna
Published 2019-07-01

Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine

by Rahul Shukla, Viswanathan Ramasamy, Rajgokul K. Shanmugam, Richa Ahuja, Navin Khanna
Published 2020-10-01

Adenovirus delivered short hairpin RNA targeting a conserved site in the 5' non-translated region inhibits all four serotypes of dengue viruses.

by Anil Babu Korrapati, Gokul Swaminathan, Aarti Singh, Navin Khanna, Sathyamangalam Swaminathan
Published 2012-01-01

Europium nanoparticle-based high performing immunoassay for the screening of treponemal antibodies.

by Sheikh M Talha, Jukka Hytönen, Adam Westhorpe, Sushil Kumar, Navin Khanna, Kim Pettersson
Published 2013-01-01

Double-Antigen Lateral Flow Immunoassay for the Detection of Anti-HIV-1 and -2 Antibodies Using Upconverting Nanoparticle Reporters

by Iida Martiskainen, Etvi Juntunen, Teppo Salminen, Karoliina Vuorenpää, Sherif Bayoumy, Tytti Vuorinen, Navin Khanna, Kim Pettersson, Gaurav Batra, Sheikh M. Talha
Published 2021-01-01

Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement

by Rahul Shukla, Rajgokul K. Shanmugam, Viswanathan Ramasamy, Upasana Arora, Gaurav Batra, Joshua A. Acklin, Florian Krammer, Jean K. Lim, Sathyamangalam Swaminathan, Navin Khanna
Published 2020-04-01

Median arcuate ligament syndrome diagnosis on Computed Tomography: what a radiologist needs to know

by Pooja Narwani, MD, DNB, FRCR, Navin Khanna, MD, Ishwariya Rajendran, DNB FRCR, Hesham Kaawan, MBBcH, MRCP UK, PG Dip, Rafid Al-Sam, FRCR
Published 2021-11-01

Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.

by Shailendra Mani, Lav Tripathi, Rajendra Raut, Poornima Tyagi, Upasana Arora, Tarani Barman, Ruchi Sood, Alka Galav, Wahala Wahala, Aravinda de Silva, Sathyamangalam Swaminathan, Navin Khanna
Published 2013-01-01

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models

by Rahul Shukla, Hemalatha Beesetti, Julia A. Brown, Richa Ahuja, Viswanathan Ramasamy, Rajgokul K. Shanmugam, Ankur Poddar, Gaurav Batra, Florian Krammer, Jean K. Lim, Sachin Kale, Altaf A. Lal, Sathyamangalam Swaminathan, Navin Khanna
Published 2020-10-01

Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes.

by Ruchi Sood, Rajendra Raut, Poornima Tyagi, Pawan Kumar Pareek, Tarani Kanta Barman, Smita Singhal, Raj Kumar Shirumalla, Vijay Kanoje, Ramesh Subbarayan, Ravisankar Rajerethinam, Navin Sharma, Anil Kanaujia, Gyanesh Shukla, Y K Gupta, Chandra K Katiyar, Pradip K Bhatnagar, Dilip J Upadhyay, Sathyamangalam Swaminathan, Navin Khanna
Published 2015-12-01

A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confe...

by Viswanathan Ramasamy, Upasana Arora, Rahul Shukla, Ankur Poddar, Rajgokul K Shanmugam, Laura J White, Melissa M Mattocks, Rajendra Raut, Ashiya Perween, Poornima Tyagi, Aravinda M de Silva, Siddhartha K Bhaumik, Murali Krishna Kaja, François Villinger, Rafi Ahmed, Robert E Johnston, Sathyamangalam Swaminathan, Navin Khanna
Published 2018-01-01